[Importance of HLA-G in therapy of cancer]

Therapie. 2008 Jul-Aug;63(4):327-32. doi: 10.2515/therapie:2008049. Epub 2008 Oct 22.
[Article in French]

Abstract

HLA-G (Human Leucocyte Antigen-G) is a non-classical HLA class I molecule observed for the first time in human cytotrophoblast. Numbers of investigations have demonstrated that HLA-G was broader than originally thought. In fact, it is expressed in pathological contexts as well as in physiological contexts. This expression of HLA-G and its receptors in immunity cells confer to it a major role in immune responses. Good issues were described in organ transplantation when HLA-G was expressed. But, HLA-G transcripts and/or proteins expression in tumor tissues was associated with tumor genesis and cancer progression. A focus on the expression and the role of HLA-G in tumor context will be developed in this review. In addition, regulation of HLA-G will be treated to improve strategies of cancer therapy.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • HLA Antigens / genetics*
  • HLA Antigens / immunology
  • HLA-G Antigens
  • Histocompatibility Antigens Class I / genetics*
  • Histocompatibility Antigens Class I / immunology
  • Humans
  • Neoplasm Invasiveness / genetics
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • HLA Antigens
  • HLA-G Antigens
  • Histocompatibility Antigens Class I